MX344141B - Preparacion solida recubierta. - Google Patents
Preparacion solida recubierta.Info
- Publication number
- MX344141B MX344141B MX2012007997A MX2012007997A MX344141B MX 344141 B MX344141 B MX 344141B MX 2012007997 A MX2012007997 A MX 2012007997A MX 2012007997 A MX2012007997 A MX 2012007997A MX 344141 B MX344141 B MX 344141B
- Authority
- MX
- Mexico
- Prior art keywords
- solid preparation
- montelukast
- coated solid
- coated
- acceptable salt
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 4
- 239000007787 solid Substances 0.000 title abstract 4
- UCHDWCPVSPXUMX-TZIWLTJVSA-N Montelukast Chemical compound CC(C)(O)C1=CC=CC=C1CC[C@H](C=1C=C(\C=C\C=2N=C3C=C(Cl)C=CC3=CC=2)C=CC=1)SCC1(CC(O)=O)CC1 UCHDWCPVSPXUMX-TZIWLTJVSA-N 0.000 abstract 4
- 229960005127 montelukast Drugs 0.000 abstract 4
- 239000004372 Polyvinyl alcohol Substances 0.000 abstract 2
- 239000004927 clay Substances 0.000 abstract 2
- 239000011247 coating layer Substances 0.000 abstract 2
- 229920002451 polyvinyl alcohol Polymers 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Un objetivo de la presente invención es proporcionar una preparación sólida recubierta que contiene montelukast, que se puede aplicar a un empaque de una dosis, en donde la estabilidad a la humedad de montelukast o una sal farmacológicamente aceptable del mismo contenida en el mismo se mantiene incluso cuando la preparación se desempaca. La presente invención proporciona una preparación sólida recubierta que contiene como un ingrediente activo montelukast o una sal farmacológicamente aceptable del mismo y que está recubierta con una capa de recubrimiento que comprende alcohol polivinílico y arcilla de expansión, en donde la relación en masa del alcohol polivinílico descrito en lo anterior respecto a la arcilla de expansión descrito en lo anterior en la capa de recubrimiento descrita en lo anterior es de 8:2 a 3:7.+.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010042066 | 2010-02-26 | ||
| PCT/JP2011/054256 WO2011105539A1 (ja) | 2010-02-26 | 2011-02-25 | 被覆固形製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2012007997A MX2012007997A (es) | 2012-08-23 |
| MX344141B true MX344141B (es) | 2016-12-07 |
Family
ID=44506936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012007997A MX344141B (es) | 2010-02-26 | 2011-02-25 | Preparacion solida recubierta. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8658208B2 (es) |
| EP (1) | EP2540298B1 (es) |
| JP (1) | JP5761018B2 (es) |
| KR (1) | KR101445671B1 (es) |
| CN (1) | CN102762205B (es) |
| BR (1) | BR112012015923A2 (es) |
| CA (1) | CA2785694C (es) |
| ES (1) | ES2552628T3 (es) |
| HU (1) | HUE026633T2 (es) |
| MX (1) | MX344141B (es) |
| PL (1) | PL2540298T3 (es) |
| SI (1) | SI2540298T1 (es) |
| TW (1) | TWI480067B (es) |
| WO (1) | WO2011105539A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI438012B (zh) | 2008-12-25 | 2014-05-21 | Toray Industries | 固態製劑用之塗覆劑及使用其之固態製劑 |
| GB2509460A (en) * | 2011-09-29 | 2014-07-02 | Meditop Gy Gyszeripari Kft | Coating Composition |
| KR101278572B1 (ko) * | 2011-10-18 | 2013-06-25 | 주식회사 네비팜 | 류코트리엔 길항제와 에피나스틴의 복합제제 |
| CN102973532A (zh) * | 2012-12-28 | 2013-03-20 | 南京瑞尔医药有限公司 | 一种稳定的孟鲁司特钠片剂及制备方法 |
| TWI658842B (zh) | 2014-03-31 | 2019-05-11 | 日商東麗股份有限公司 | 固體製劑用之被覆劑以及由其所形成之被膜及被覆固體製劑 |
| JP7194524B2 (ja) * | 2018-06-25 | 2022-12-22 | 日本酢ビ・ポバール株式会社 | コーティング組成物並びに経口固形剤及びその製造方法 |
| CN112789037A (zh) | 2018-09-06 | 2021-05-11 | 创新药物筛选有限公司 | 用于治疗哮喘或帕金森病的方法和药物组合物 |
| US20210113715A1 (en) * | 2018-09-14 | 2021-04-22 | Cedars-Sinai Medical Center | Targeted nanoparticles for diagnosing, detecting and treating cancer |
| JPWO2023224097A1 (es) * | 2022-05-18 | 2023-11-23 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5157815A (en) * | 1974-11-14 | 1976-05-20 | Sumitomo Chemical Co | Toijono seizohoho |
| JPS5942325A (ja) * | 1982-09-03 | 1984-03-08 | Dai Ichi Seiyaku Co Ltd | コ−テイング用組成物及びコ−テイング製剤 |
| JPS61186313A (ja) | 1985-02-12 | 1986-08-20 | Dainippon Pharmaceut Co Ltd | バルプロ酸ナトリウム製剤 |
| JP2803179B2 (ja) * | 1989-06-28 | 1998-09-24 | 東洋紡績株式会社 | 被覆プラスチックフイルム |
| JPH03120211A (ja) | 1989-10-04 | 1991-05-22 | Earth Chem Corp Ltd | 粒状カルニチン製剤 |
| AU662429B2 (en) * | 1992-07-29 | 1995-08-31 | Sumitomo Chemical Company, Limited | Gas barrier resin composition and its film and process for producing the same |
| DE670160T1 (de) * | 1994-03-01 | 1996-03-14 | Gergely, Gerhard, Dr., Wien | Ein Brausesystem und einen Arzneiwirkstoff enthaltendes granuläres Produkt bzw. Tablette sowie Verfahren zu deren Herstellung. |
| HU225964B1 (en) * | 1994-07-12 | 2008-01-28 | Berwind Pharma Service | Moisture barrier film coating composition, method, and coated form |
| US5773031A (en) | 1996-02-27 | 1998-06-30 | L. Perrigo Company | Acetaminophen sustained-release formulation |
| CA2403831C (en) | 2001-02-27 | 2009-11-24 | Evonik Operations Gmbh | Coating and binding agent for pharmaceutical formulations having improved storage stability |
| NL1018607C2 (nl) * | 2001-07-20 | 2003-01-21 | Friesland Brands Bv | Vochtbarrière in voedingsmiddelen. |
| IL174758A (en) | 2003-10-10 | 2012-09-24 | Synthon Bv | Crystalline form of montelukast, pharmaceutical composition comprising it, process for the preparation thereof and uses thereof as a medicament |
| EP1711166A1 (en) | 2004-02-03 | 2006-10-18 | Chemagis Ltd. | Stable amorphous forms of montelukast sodium |
| JP2007145717A (ja) | 2005-11-24 | 2007-06-14 | Eisai R & D Management Co Ltd | フィルムコーティング製剤 |
| ES2277563B1 (es) * | 2005-12-29 | 2008-06-16 | Nanobiomatters, S.L. | Procedimiento de fabricacion de materiales nanocompuestos para aplicaciones multisectoriales. |
| EP1803457A1 (en) * | 2005-12-30 | 2007-07-04 | Krka Tovarna Zdravil, D.D., Novo Mesto | Pharmaceutical composition containing montelukast |
| AU2006337648A1 (en) * | 2006-02-09 | 2007-08-16 | Teva Pharmaceutical Industries Ltd. | Stable pharmaceutical formulations of montelukast sodium |
| GB0709541D0 (en) | 2007-05-17 | 2007-06-27 | Jagotec Ag | Pharmaceutical excipient |
| US20090124657A1 (en) * | 2007-08-14 | 2009-05-14 | Ramesh Kappala | Pharmaceutical compositions comprising montelukast |
| TWI438012B (zh) * | 2008-12-25 | 2014-05-21 | Toray Industries | 固態製劑用之塗覆劑及使用其之固態製劑 |
| HUE030830T2 (en) | 2009-03-27 | 2017-06-28 | Toray Industries | Covered solid preparation |
-
2011
- 2011-02-25 CA CA2785694A patent/CA2785694C/en not_active Expired - Fee Related
- 2011-02-25 MX MX2012007997A patent/MX344141B/es active IP Right Grant
- 2011-02-25 HU HUE11747495A patent/HUE026633T2/en unknown
- 2011-02-25 PL PL11747495T patent/PL2540298T3/pl unknown
- 2011-02-25 WO PCT/JP2011/054256 patent/WO2011105539A1/ja not_active Ceased
- 2011-02-25 CN CN201180011164.9A patent/CN102762205B/zh not_active Expired - Fee Related
- 2011-02-25 TW TW100106314A patent/TWI480067B/zh not_active IP Right Cessation
- 2011-02-25 US US13/581,010 patent/US8658208B2/en not_active Expired - Fee Related
- 2011-02-25 BR BR112012015923-2A patent/BR112012015923A2/pt active Search and Examination
- 2011-02-25 EP EP11747495.7A patent/EP2540298B1/en not_active Not-in-force
- 2011-02-25 JP JP2011509337A patent/JP5761018B2/ja not_active Expired - Fee Related
- 2011-02-25 ES ES11747495.7T patent/ES2552628T3/es active Active
- 2011-02-25 SI SI201130706T patent/SI2540298T1/sl unknown
- 2011-02-25 KR KR1020127018048A patent/KR101445671B1/ko not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| BR112012015923A2 (pt) | 2020-09-08 |
| EP2540298B1 (en) | 2015-11-04 |
| ES2552628T3 (es) | 2015-12-01 |
| PL2540298T3 (pl) | 2016-04-29 |
| EP2540298A1 (en) | 2013-01-02 |
| CN102762205A (zh) | 2012-10-31 |
| CA2785694A1 (en) | 2011-09-01 |
| HUE026633T2 (en) | 2016-06-28 |
| CA2785694C (en) | 2013-12-17 |
| MX2012007997A (es) | 2012-08-23 |
| US20120321677A1 (en) | 2012-12-20 |
| CN102762205B (zh) | 2014-03-12 |
| JPWO2011105539A1 (ja) | 2013-06-20 |
| KR101445671B1 (ko) | 2014-09-29 |
| WO2011105539A1 (ja) | 2011-09-01 |
| SI2540298T1 (sl) | 2016-02-29 |
| TWI480067B (zh) | 2015-04-11 |
| EP2540298A4 (en) | 2014-04-09 |
| TW201136618A (en) | 2011-11-01 |
| US8658208B2 (en) | 2014-02-25 |
| KR20120098877A (ko) | 2012-09-05 |
| JP5761018B2 (ja) | 2015-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2012007997A (es) | Preparacion solida recubierta. | |
| AU2012259422A8 (en) | Solid forms of a pharmaceutically active substance | |
| EA201291028A1 (ru) | Полипропиленовая композиция, подходящая для нанесения покрытий экструзией | |
| DK2282994T3 (da) | 3-aminocarbazolforbindelse, farmaceutisk sammensætning indeholdende forbindelsen samt fremstillingsmetode derfor | |
| LT3216448T (lt) | Paraziticidinės peroralinės veterinarinės kompozicijos, apimančios sisteminio poveikio veikliuosius agentus, būdai ir jų panaudojimas | |
| WO2011049309A3 (ko) | 속효성과 지속성을 동시에 갖는 약제학적 조성물 | |
| JP2013510216A5 (es) | ||
| WO2013130898A3 (en) | Stabilizing agents and methods of use thereof | |
| WO2011155793A3 (en) | Pharmaceutical composition comprising amide derivative or pharmaceutically acceptable salt thereof | |
| TN2012000371A1 (en) | Pyrazole compounds as crth2 antagonists | |
| WO2012048176A3 (en) | Attachment and retention formulations for biologically active organic compounds | |
| LT2658844T (lt) | Nauji pirimidino dariniai, jų gamyba ir jų farmacinis panaudojimas kaip akt (pkb) fosforilinimo slopiklių | |
| WO2012001705A3 (en) | Pharmaceutical compositions of (r)-lansoprazole | |
| MX344324B (es) | Endoprotesis que contiene un recubrimiento de substancia activa. | |
| WO2011140446A3 (en) | Pharmaceutical formulations | |
| EP2496083A4 (en) | NICOTINE-CONTAINING FORMULATION | |
| EP2630956B8 (en) | Sustained-release pellets containing tacrolimus as an active ingredient | |
| WO2012074830A3 (en) | Modified release tranexamic acid formulation | |
| WO2012075015A3 (en) | Oral metronidazole pharmaceutical compositions | |
| WO2014149176A3 (en) | Use of chromobacterium substugae formulations, compositions and compounds to modulate cornworm rootworm larvae infestation | |
| WO2011139728A3 (en) | Packaging for electrochemically active materials, devices made therefrom, and methods of making the same | |
| CA2750209A1 (en) | Coated solid preparations of valproic acid | |
| MX336924B (es) | Formulacion inyectable de una lactona macrociclica y levamisol. | |
| IL206739A (en) | An injectable drug containing silitol as an active substance | |
| WO2014181195A3 (en) | Antiemetic extended release solid dosage forms |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |